Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982777priorityCriticalpatent/ECSP982777A/en
Publication of ECSP982777ApublicationCriticalpatent/ECSP982777A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
La invención es una combinación farmacéutica que comprende un éter carboxialquilico que reduce los triglicéridos y HDL elevado y una estatina que inhibe la reductasa HMG-CoA, reduciendo asi LDL, dicha composición es útil para el tratamiento de enfermedades vasculares.The invention is a pharmaceutical combination comprising a carboxy alkyl ether that reduces triglycerides and high HDL and a statin that inhibits HMG-CoA reductase, thus reducing LDL, said composition is useful for the treatment of vascular diseases.
USE OF A HYDROXYLED CHOLESTEROL COMPOSITE AS A REDUCING AGENT TO PREPARE A PHARMACEUTICAL USE COMPOSITION IN A METHOD TO INHIBIT THE OXIDATION OF LIPOPROTEINS IN A MAMMER.
2-OPTICALLY ACTIVE AMINOTETRALINE, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT, ACTIVE IN THE PREVENTION AND TREATMENT OF SEPTIC SHOCK.